Breaking News Instant updates and real-time market news.

CATB

Catabasis Pharmaceuticals

$0.86

-0.03 (-3.38%)

12:36
07/10/18
07/10
12:36
07/10/18
12:36

Federated Investors reports 14.7% passive stake in Catabasis Pharmaceuticals

CATB Catabasis Pharmaceuticals
$0.86

-0.03 (-3.38%)

08/14/17
OPCO
08/14/17
NO CHANGE
Target $4
OPCO
Outperform
Catabasis Pharmaceuticals price target lowered to $4 from $9 at Oppenheimer
Oppenheimer analyst Hartaj Singh lowered his price target for Catabasis Pharmaceuticals to $4 from $9 as a comprehensive Phase 3 program potentially pushes out sales timelines and reduces sales potential. The analyst reiterates an Outperform rating on the shares.
09/29/17
SBSH
09/29/17
NO CHANGE
Target $1.5
SBSH
Neutral
PTC panel vote not favorable for Catabasis despite share rally, says Citi
Catabasis Pharmaceuticals (CATB) shares traded 22% higher yesterday as an FDA panel considered the approval of PTC Therapeutics' (PTCT) Duchenne muscular dystrophy agent Translarna, Citi analyst Joel Beatty tells investors in a research note. The general tone of FDA comments support the view that the agency is willing to be flexible with regards to accepting a variety of outcomes as approvable endpoints in DMD, as long as they are prospectively defined, Beatty contends. The analyst, however, thinks Catabasis' edasalonexent and Translarna would likely be used synergistically and would not be competitors. As such, he does not see the negative vote at yesterday's panel meeting as being favorable for Catabasis. Beatty keeps a Neutral rating on Catabasis shares with a $1.50 price target. The stock closed yesterday up 22%, or 40c, to $2.23.
10/05/17
OPCO
10/05/17
NO CHANGE
Target $7
OPCO
Outperform
Catabasis Pharmaceuticals price target raised to $7 from $4 at Oppenheimer
Oppenheimer analyst Hartaj Singh raised his price target for Catabasis Pharmaceuticals to $7 from $4 after the company reported positive 36-week data from the ongoing Part C open label extension of its Phase 2 MoveDMD clinical trial in Duchenne muscular dystrophy. The analyst reiterates an Outperform rating on the shares.
11/20/17
SBSH
11/20/17
UPGRADE
Target $2.5
SBSH
Buy
Catabasis Pharmaceuticals upgraded to Buy from Neutral at Citi
Citi analyst Joel Beatty upgraded Catabasis Pharmaceuticals to Buy while lowering his price target for the shares to $2.50 from $3.50. Non-dilutive funding is possible for the Phase 3 trial given its low cost, which could provide upside to the current share price, Beatty tells investors in a research note. He believes the extension study data in Q1 of 2018 could help attract some non-dilutive financing.

TODAY'S FREE FLY STORIES

LABD

Daily S&P Biotech Bear 3x Shares

$21.90

0.15 (0.69%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAR

Saratoga Investment

$24.63

-0.08 (-0.32%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Upgrade
Saratoga Investment rating change  »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

EWH

MSCI Hong Kong Index

$24.46

0.07 (0.29%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNT

Innovate Biopharmaceuticals

$23.72

0.12 (0.51%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Conference/Events
Innovate Biopharmaceuticals management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EWG

iShares MSCI Germany

$30.64

0.095 (0.31%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$19.00

0.4 (2.15%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

IJR

iShares Core S&P Small Cap ETF

$85.89

-0.07 (-0.08%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$16.37

0.01 (0.06%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Downgrade
Sally Beauty rating change  »

Sally Beauty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

GLYC

GlycoMimetics

$17.12

0.32 (1.90%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Conference/Events
GlycoMimetics management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EEM

MSCI Emerging Markets Index

$43.86

0.06 (0.14%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAT

Waters

$198.07

-0.5 (-0.25%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Downgrade
Waters rating change  »

Waters downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SAR

Saratoga Investment

$24.63

-0.08 (-0.32%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Downgrade
Saratoga Investment rating change  »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ENZ

Enzo Biochem

$5.13

-0.01 (-0.19%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Conference/Events
Enzo Biochem management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PJT

PJT Partners

$56.90

-0.08 (-0.14%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Downgrade
PJT Partners rating change  »

PJT Partners downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCEL

Vericel

$9.05

-1.05 (-10.40%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Upgrade
Vericel rating change  »

Vericel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$50.24

-0.21 (-0.42%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$96.50

-0.87 (-0.89%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Downgrade
Hasbro rating change  »

Hasbro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

XERS

Xeris Pharmaceuticals

$18.26

-0.18 (-0.98%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Initiation
Xeris Pharmaceuticals initiated  »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAE

CAE

$20.84

-0.15 (-0.71%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Conference/Events
CAE management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

UUP

PowerShares DB US Dollar Index Up

$25.01

-0.02 (-0.08%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$21.61

(0.00%)

06:36
07/16/18
07/16
06:36
07/16/18
06:36
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$129.54

2.18 (1.71%)

06:35
07/16/18
07/16
06:35
07/16/18
06:35
Hot Stocks
United Technologies consortium, Vietnam Airlines sign three-year agreement »

Vietnam Airlines has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HPQ

HP Inc.

$23.71

0.18 (0.76%)

06:35
07/16/18
07/16
06:35
07/16/18
06:35
Recommendations
HP Inc. analyst commentary  »

HP has 'multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPRT

Essential Properties Realty Trust

$14.00

(0.00%)

06:33
07/16/18
07/16
06:33
07/16/18
06:33
Initiation
Essential Properties Realty Trust initiated  »

Essential Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$41.39

-1.18 (-2.77%)

06:33
07/16/18
07/16
06:33
07/16/18
06:33
Conference/Events
ShotSpotter management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.